Correlation Between Gossamer Bio and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Gossamer Bio and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gossamer Bio and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gossamer Bio and X4 Pharmaceuticals, you can compare the effects of market volatilities on Gossamer Bio and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gossamer Bio with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gossamer Bio and X4 Pharmaceuticals.
Diversification Opportunities for Gossamer Bio and X4 Pharmaceuticals
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Gossamer and XFOR is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Gossamer Bio and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Gossamer Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gossamer Bio are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Gossamer Bio i.e., Gossamer Bio and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Gossamer Bio and X4 Pharmaceuticals
Given the investment horizon of 90 days Gossamer Bio is expected to under-perform the X4 Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Gossamer Bio is 5.97 times less risky than X4 Pharmaceuticals. The stock trades about -0.32 of its potential returns per unit of risk. The X4 Pharmaceuticals is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 53.00 in X4 Pharmaceuticals on September 4, 2024 and sell it today you would lose (16.00) from holding X4 Pharmaceuticals or give up 30.19% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gossamer Bio vs. X4 Pharmaceuticals
Performance |
| Timeline |
| Gossamer Bio |
| X4 Pharmaceuticals |
Gossamer Bio and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gossamer Bio and X4 Pharmaceuticals
The main advantage of trading using opposite Gossamer Bio and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gossamer Bio position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| Gossamer Bio vs. Biomea Fusion | Gossamer Bio vs. Stoke Therapeutics | Gossamer Bio vs. Akero Therapeutics | Gossamer Bio vs. Replimune Group |
| X4 Pharmaceuticals vs. Candel Therapeutics | X4 Pharmaceuticals vs. Cingulate Warrants | X4 Pharmaceuticals vs. Unicycive Therapeutics | X4 Pharmaceuticals vs. Cardio Diagnostics Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |